Lanean...
Therapeutic Antibodies for Myeloid Neoplasms—Current Developments and Future Directions
Therapeutic monoclonal antibodies (mAbs) such as antibody–drug conjugates, ligand–receptor antagonists, immune checkpoint inhibitors and bispecific T cell engagers have shown impressive efficacy in the treatment of multiple human cancers. Numerous therapeutic mAbs that have been developed for myeloi...
Gorde:
| Argitaratua izan da: | Front Oncol |
|---|---|
| Egile nagusia: | |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Frontiers Media S.A.
2018
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5968093/ https://ncbi.nlm.nih.gov/pubmed/29868474 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2018.00152 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|